A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

NCT07488676 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Pancreatic Adenocarcinoma

Interventions

DRUG: ASP546C

Sponsor

Astellas Pharma Global Development, Inc.